These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6775686)

  • 1. Factor VIII related antigen/coagulant activity ratio as a predictor of fetal growth retardation: a comparison with hormone and uric acid measurements.
    Whigham KA; Howie PW; Shah MM; Prentice CR
    Br J Obstet Gynaecol; 1980 Sep; 87(9):797-803. PubMed ID: 6775686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which is the best placental function test? A comparison of placental lactogen and unconjugated oestriol in the prediction of intrauterine growth retardation.
    Chard T; Sturdee J; Cockrill B; Obiekwe BC
    Eur J Obstet Gynecol Reprod Biol; 1985 Jan; 19(1):13-7. PubMed ID: 3979650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal placental functions and intrauterine growth retardation in patients with positive contraction stress tests.
    Odendaal HJ; Malan C; Oosthuizen J
    S Afr Med J; 1981 May; 59(23):822-4. PubMed ID: 7233299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of total serum oestriol and human placental lactogen in the assessment of fetal-placental function.
    Isouard G
    Aust N Z J Obstet Gynaecol; 1979 May; 19(2):69-76. PubMed ID: 292431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of human placental lactogen, oxytocinase and estriol in twin pregnancies with intrauterine growth retardation.
    Briët JW; Hoorn RK
    Eur J Obstet Gynecol Reprod Biol; 1982 Feb; 13(1):7-14. PubMed ID: 7060818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The value of biochemical parameters in the prenatal diagnosis of intrauterine growth retardation].
    Holtorff J; Beutner M; Schollberg K
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():15-21. PubMed ID: 6211043
    [No Abstract]   [Full Text] [Related]  

  • 7. Fetal biparietal diameter and maternal plasma concentrations of placental lactogen, chorionic gonadotrophin, oestriol, and alpha-fetoprotein in normal and pathological pregnancies.
    Persson PH; Grennert L; Gennser G; Eneroth P
    Br J Obstet Gynaecol; 1980 Jan; 87(1):25-32. PubMed ID: 6153901
    [No Abstract]   [Full Text] [Related]  

  • 8. [Detection of fetal growth retardation by instrumental and biochemical monitoring methods].
    Pfeiffer KH
    Z Geburtshilfe Perinatol; 1990; 194(3):99-103. PubMed ID: 2198727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human placental lactogen and unconjugated estriol concentrations in twin pregnancy: monitoring of fetal development in intrauterine growth retardation and single intrauterine fetal death.
    Trapp M; Kato K; Bohnet HG; Gerhard I; Weise HC; Leidenberger F
    Am J Obstet Gynecol; 1986 Nov; 155(5):1027-31. PubMed ID: 3777044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The value of fetal blood flow measurements in intrauterine growth retardation in comparison with E3 and human placental lactogen determinations].
    Spernol R; Hecher K; Szalay S
    Geburtshilfe Frauenheilkd; 1989 May; 49(5):463-5. PubMed ID: 2661312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor VIII-related antigen and factor VIII coagulant activity in normal and pre-eclamptic pregnancy.
    Thornton CA; Bonnar J
    Br J Obstet Gynaecol; 1977 Dec; 84(12):919-23. PubMed ID: 588503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma oestriol and human placental lactogen measurements in patients with high risk pregnancies.
    Edwards RP; Diver MJ; Davis JC; Hipkin LJ
    Br J Obstet Gynaecol; 1976 Mar; 83(3):229-37. PubMed ID: 1252389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormally elevated pregnancy specific beta 1 glycoprotein (SP1 beta) with very low placental lactogen (hPL) concentrations in a pregnancy with satisfactory outcome.
    Pledger DR; McEwan HP
    Acta Obstet Gynecol Scand; 1984; 63(7):663-5. PubMed ID: 6393689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prediction of fetal growth retardation in twin pregnancy.
    Houlton MC; Marivate M; Philpott RH
    Br J Obstet Gynaecol; 1981 Mar; 88(3):264-73. PubMed ID: 7470417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of "carrier screening" of hemophilia by the ratio of factor VIII coagulant activity or antigen to factor VIII related antigen.
    Ekert H; Dean F
    Aust N Z J Med; 1983 Oct; 13(5):463-7. PubMed ID: 6418126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The factor VIII ratio in normal and pathological pregnancies.
    Scholtes MC; Gerretsen G; Haak HL
    Eur J Obstet Gynecol Reprod Biol; 1983 Oct; 16(2):89-95. PubMed ID: 6416905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of biochemical assays in assessing an IUGR risk-group, preselected with ultrasound fetometry.
    Laurin J; Persson PH; Fernlund P
    Eur J Obstet Gynecol Reprod Biol; 1987 Mar; 24(3):177-87. PubMed ID: 2951284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of human procoagulant factor VIII (VIIIC) antibodies in their reaction with factor VIII related antigen (VIIIRAG).
    Furlong RA; Peake IR
    Thromb Res; 1984 Jun; 34(5):379-87. PubMed ID: 6204399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weight percentile at birth. II. Prediction by endocrinological and sonographic measurements.
    Gerhard I; Vollmar B; Runnebaum B; Klinga K; Haller U; Kubli F
    Eur J Obstet Gynecol Reprod Biol; 1987 Dec; 26(4):313-28. PubMed ID: 3319732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placental alkaline phosphatase compared with human placental lactogen and oestriol in high-risk pregnancies.
    Ronin-Walknowska E; Holmgren PA; von Schoultz B; Stigbrand T
    Gynecol Obstet Invest; 1984; 18(4):206-11. PubMed ID: 6510780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.